U.S. SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                   Form 10-QSB


[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934: FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2002

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT
     For the transition period from ____________ to ____________.


                         Commission File Number 1-13012

                      H.E.R.C. PRODUCTS INCORPORATED
          (Name of small business issuer as specified in its charter)

State of Incorporation: Delaware  IRS Employer Identification Number: 86-0570800

                          2215 W Melinda Lane, Suite A
                             Phoenix, Arizona 85027
                    (Address of principal executive offices)

                                 (623) 492-0336
                           (Issuer's telephone number)

Check whether the issuer:  (1) filed all reports required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. YES [X] NO [ ]

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date.


          Class                                 Outstanding at November 12, 2002
          -----                                 --------------------------------
Common Stock, $.01 par value                                12,054,873

Transitional Small Business Disclosure Format: YES [ ] NO [X]

                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES


Index To Consolidated Financial Statements

PART I. FINANCIAL INFORMATION                                           Page No.

     Item 1. Financial Statements

        Consolidated Financial Statements:
        Consolidated Balance Sheets
          September 30, 2002 and December 31, 2001                             3
        Consolidated Statements of Operations
          Three and Nine Months Ended September 30, 2002 and 2001              4
        Consolidated Statements of Cash Flows
          Nine Months Ended September 30, 2002 and 2001                        5

        Notes to Consolidated Financial Statements                             6

     Item 2. Management's Discussion and Analysis of Financial
               Condition and Results of Operations                            12

     Item 3. Controls and Procedures                                          17

PART II.  OTHER INFORMATION

     Item 2 - Changes in Securities                                           18

     Item 6 - Exhibits and Reports on Form 8-K                                18

Signatures                                                                    18

Certifications                                                                19

Item 1. FINANCIAL STATEMENTS

                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES

                           Consolidated Balance Sheets



                                                                             September 30,   December 31,
                                                                                 2002            2001
                                                                             ------------    ------------
                                                                             (Unaudited)
                                                                                       
                                     ASSETS
CURRENT ASSETS
  Cash                                                                       $    121,158    $     75,759
  Trade accounts receivable, net of allowance for
    doubtful accounts of $124,338 and $35,269, respectively                       802,526         602,468
  Inventories                                                                      52,740          27,061
  Costs of uncompleted contracts                                                  107,529         150,530
  Costs and estimated earnings in excess
    of billings on uncompleted contracts                                           34,582          74,289
  Other receivables, includes unbilled amounts of $33,750 and
    $53,437, respectively                                                          53,852          66,112
  Prepaid expenses                                                                250,046          51,008
                                                                             ------------    ------------
        Total Current Assets                                                    1,422,433       1,047,227
                                                                             ------------    ------------

PROPERTY AND EQUIPMENT
  Property and equipment                                                        1,535,699       1,374,993
  Less: accumulated depreciation                                               (1,103,554)       (938,755)
                                                                             ------------    ------------
        Net Property and Equipment                                                432,145         436,238
                                                                             ------------    ------------

OTHER ASSETS
  Patents, net of accumulated amortization of $116,101 and
    $100,397, respectively                                                        108,034         107,366
  Patents pending                                                                 115,198         117,954
  Refundable deposits and other assets                                              8,722           9,940
                                                                             ------------    ------------
        Total Other Assets                                                        231,954         235,260
                                                                             ------------    ------------
                                                                             $  2,086,532    $  1,718,725
                                                                             ============    ============
                      LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES
  Accounts payable                                                           $    417,226    $    287,259
  Accrued wages                                                                    62,642         117,350
  Current portion of notes payable                                                 69,907          19,944
  Other accrued expenses                                                          380,644         225,267
                                                                             ------------    ------------
        Total Current Liabilities                                                 930,419         649,820

LONG-TERM LIABILITIES
  Notes payable, net of current portion                                                --           2,570
                                                                             ------------    ------------
        Total Liabilities                                                         930,419         652,390
                                                                             ------------    ------------

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY
  Preferred stock, $0.01 par value; authorized 1,000,000 shares;
    issued and outstanding zero shares                                                 --              --
  Common stock, $0.01 par value; authorized 40,000,000 shares;
    issued and outstanding 12,004,872 and 11,864,872 shares, respectively,        120,049         118,649
  Additional paid-in capital                                                   14,025,064      14,012,464
  Accumulated deficit                                                         (12,989,000)    (13,064,778)
                                                                             ------------    ------------
        Total Stockholders' Equity                                              1,156,113       1,066,335
                                                                             ------------    ------------
                                                                             $  2,086,532    $  1,718,725
                                                                             ============    ============


              The accompanying notes are an integral part of this
                          consolidated balance sheet.

                                                                               3

                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES

                      Consolidated Statements of Operations
                                   (Unaudited)



                                                             Three Months Ended              Nine Months Ended
                                                                September 30,                   September 30,
                                                        ----------------------------    ----------------------------
                                                            2002            2001            2002            2001
                                                        ------------    ------------    ------------    ------------
                                                                                            
SALES                                                   $  1,770,863    $  1,740,621    $  4,943,250    $  4,311,629
COST OF SALES                                                927,071         894,290       2,713,420       2,454,111
                                                        ------------    ------------    ------------    ------------
GROSS PROFIT                                                 843,792         846,331       2,229,830       1,857,518
SELLING EXPENSES                                             123,471          60,455         378,811         199,790
GENERAL AND ADMINISTRATIVE EXPENSES                          762,759         560,920       1,943,022       1,739,467
                                                        ------------    ------------    ------------    ------------
OPERATING PROFIT (LOSS)                                      (42,438)        224,956         (92,003)        (81,739)
                                                        ------------    ------------    ------------    ------------
OTHER INCOME (EXPENSE)
  Gain on sale of asset                                           --              --              --          52,378
  Interest expense                                           (18,110)        (18,354)        (58,171)        (45,709)
  Miscellaneous                                                  262           1,458         225,952           5,393
                                                        ------------    ------------    ------------    ------------
      Total Other Income (Expense)                           (17,848)        (16,896)        167,781          12,062
                                                        ------------    ------------    ------------    ------------
NET INCOME (LOSS) BEFORE INCOME TAXES                        (60,286)        208,060          75,778         (69,677)
  Income tax provision                                            --              --              --              --
                                                        ------------    ------------    ------------    ------------
NET INCOME (LOSS)                                       $    (60,286)   $    208,060    $     75,778    $    (69,677)
                                                        ============    ============    ============    ============

NET INCOME (LOSS) PER COMMON SHARE -BASIC AND DILUTED          (0.01)           0.02    $       0.01    $      (0.01)
                                                        ============    ============    ============    ============

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
BASIC                                                     12,004,872      11,798,206      11,951,905      11,768,713
                                                        ============    ============    ============    ============
DILUTED                                                   12,004,872      11,798,788      12,025,470      11,768,713
                                                        ============    ============    ============    ============


              The accompanying notes are an integral part of these
                       consolidated financial statements.

                                                                               4

                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES

                      Consolidated Statements of Cash Flows
                                   (Unaudited)



                                                                         Nine Months Ended
                                                                           September 30,
                                                                      ----------------------
                                                                         2002         2001
                                                                      ---------    ---------
                                                                             
CASH FLOWS FROM OPERATING ACTIVITIES
  Net income (loss)                                                   $  75,778    $ (69,677)
  Adjustments to reconcile net loss to net cash
    provided by (used in) operating activities
      Depreciation and amortization                                     180,976      192,667
      Gain on sale of Chlor-Rid(R)rights                               (225,000)          --
      Gain on sale of asset                                                  --      (52,378)
      Common stock issued for services                                   14,000       18,000
      Bad debt expense                                                   89,069           --
      (Increase) decrease in assets
        Trade accounts receivable                                      (289,127)    (430,962)
        Inventories                                                     (25,679)      12,184
        Costs of uncompleted contracts                                   43,001     (282,231)
        Costs and estimated earnings in excess of billings
          on uncompleted contracts                                       39,707           --
        Other receivables                                                12,260       (5,449)
        Prepaid expenses                                                170,076      144,776
        Refundable deposits and other assets                              1,218        1,982
      Increase (decrease) in liabilities
        Accounts payable                                                129,967      428,574
        Accrued wages and other accrued expenses                        100,669      125,061
        Customer deposits                                                    --       (6,035)
                                                                      ---------    ---------
            Net cash provided by operating activities                   316,915       76,512
                                                                      ---------    ---------
CASH FLOWS FROM INVESTING ACTIVITIES
  Capital expenditures                                                 (160,707)     (82,672)
  Cash received from sale of Chlor-Rid(R)rights                         225,000           --
  Cash received from sale of asset                                           --      135,000
  Expenditures related to patents and patents pending                   (14,088)     (38,820)
                                                                      ---------    ---------
            Net cash provided by investing activities                    50,205       13,508
                                                                      ---------    ---------
CASH FLOWS FROM FINANCING ACTIVITIES
  Principal payments under notes payable                               (321,721)    (307,479)
                                                                      ---------    ---------
            Net cash used in financing activities                      (321,721)    (307,479)
                                                                      ---------    ---------
NET INCREASE (DECREASE) IN CASH                                          45,399     (217,459)
CASH AT BEGINNING OF PERIOD                                              75,759      302,392
                                                                      ---------    ---------
CASH AT END OF PERIOD                                                 $ 121,158    $  84,933
                                                                      =========    =========

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION

Cash paid during the period for interest                              $  58,171    $  45,709
                                                                      =========    =========
Cash paid during the period for income taxes                          $      --    $      --
                                                                      =========    =========

SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES

Prepaid insurance financed with notes payable                         $ 369,114    $ 198,262
                                                                      =========    =========


              The accompanying notes are an integral part of these
                       consolidated financial statements.

                                                                               5

                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)

NOTE 1 - BASIS OF PRESENTATION

The accompanying  unaudited  consolidated  financial  statements (except for the
balance  sheet at December  31, 2001,  which is derived  from audited  financial
statements)  have  been  prepared  in  accordance  with  accounting   principles
generally  accepted  in the  United  States of  America  for  interim  financial
information  and with the  requirements  of regulation S-B of the Securities and
Exchange  Commission  and  consequently  do not include  all of the  disclosures
normally made in complete annual financial  statement filing.  Accordingly,  the
consolidated  financial statements of H.E.R.C.  Products  Incorporated  included
herein  should  be  reviewed  in  conjunction  with the  consolidated  financial
statements and the  accompanying  footnotes  included  within the Company's Form
10-KSB for the year ended December 31, 2001.

In the opinion of management,  the consolidated financial statements reflect all
adjustments  necessary to fairly  report the  Company's  financial  position and
results of operations for the interim  period.  All such  adjustments are normal
and recurring in nature. The interim  consolidated results of operations are not
necessarily  indicative  of results to be expected for the year ending  December
31, 2002.

Certain  items on the  consolidated  statements of cash flows for the year ended
September  30,  2001  have  been   reclassified   to  be  consistent   with  the
classifications adopted for the period ended September 30, 2002.

NOTE 2 - REVENUE RECOGNITION

For chemical product sales, the Company  recognizes revenue at the time products
are shipped to  customers.  For most service  projects,  the Company  recognizes
revenue and costs when the services are completed.  For fixed price contracts in
excess of three month  duration,  revenue is  recognized  on the  percentage  of
completion  method,  measured  by the  percentage  of cost  incurred  to date to
estimated total cost for each contract.  This method is used because  management
considers  total  cost to be the best  available  measure of  progress  on these
contracts.

Contract costs include all direct material,  labor,  subcontract labor and other
costs related to contract performance,  such as indirect labor, supplies,  tools
and repairs. Selling, general and administrative costs are charged to expense as
incurred.  Provisions for estimated losses on uncompleted  contracts are made in
the period in which such losses are determined.  Changes in job performance, job
conditions,  and estimated profitability,  including those arising from contract
penalty  provisions  and final contract  settlements  may result in revisions to
estimates  of contract  costs and profits  and are  recognized  in the period in
which the revisions are determined.

                                                                               6

The  current  asset,  "costs and  estimated  earnings  in excess of  billings on
uncompleted  contracts"  represents  revenue  recognized  in excess  of  amounts
billed.  The  current  liability,  "billings  in excess of costs on  uncompleted
contracts," represents billings in excess of revenue recognized.

NOTE 3 - AGREEMENT WITH FACTOR

The Company has a factoring agreement with the following terms:

The factor  purchases  eligible  receivables  and advances 85% of the  purchased
amount to the Company.  Purchased  receivables may not exceed  $1,000,000 at any
time.  Either party may cancel the arrangement with 30 days notice. At September
30, 2002,  there was $616,401 of factored  receivables  of which the Company has
received $523,941 from the factor.  This $523,941 and $4,623 in interest expense
are  not  included  in  accounts  receivable  as of  September  30,  2002.  This
arrangement  is accounted for as a sale of  receivables  on which the factor has
recourse to the 15% residual of aggregate receivables purchased and outstanding.
Interest  payable by the Company to the factor is calculated as a fixed discount
fee equal to .75% of the amount of the receivable factored plus a variable (1.5%
above the institutions base rate, with a minimum of 7%) discount fee computed on
the amount  advanced  to the  Company  and  accruing on the basis of actual days
elapsed  from the date of the 85% advance  until five days after  collection  of
such account  receivable  by the factor at a per annum rate equal to an internal
rate set by the factor.  The rate at  September  30, 2002 was 7%. In  connection
with this  agreement,  the Company is required  to  maintain  certain  financial
covenants.  In the event of a breach of  representation,  warranty or agreement,
the factor has a security interest in the Company's assets.

NOTE 4 - SEGMENT INFORMATION

Information by segment for the three months ended and as of September 30, 2002:



                                          Pipe           Tank
                                        Cleaning       Cleaning      Chemicals     Corporate     Consolidated
                                       -----------    -----------   -----------    ---------     ------------
                                                                                   
     Sales to unaffiliated customers   $   352,779    $ 1,384,485   $    33,599    $        --    $ 1,770,863
     Net income (loss)                    (200,133)       508,870       (28,615)      (340,408)       (60,286)
     Total assets                          494,272        919,995        31,764        640,501      2,086,532
     Depreciation and amortization          39,341         18,458         1,643          9,136         68,578
     Capital expenditures                    2,050         96,966            --             --         99,016


                                                                               7

Information by segment for the three months ended and as of September 30, 2001:



                                          Pipe          Tank
                                        Cleaning      Cleaning      Chemicals     Corporate     Consolidated
                                       -----------   -----------   -----------   -----------    ------------
                                                                                 
     Sales to unaffiliated customers   $ 1,055,988   $   582,670   $   101,963   $        --    $ 1,740,621
     Net income (loss)                     333,734       148,834        65,656      (340,164)       208,060
     Total assets                          945,542       566,597        63,883       506,318      2,082,340
     Depreciation and amortization          46,924         5,727         1,579        11,215         65,445
     Capital expenditures                   12,334        31,727            --            --         44,061


Information by segment for the nine months ended and as of September 30, 2002:



                                          Pipe          Tank
                                        Cleaning      Cleaning      Chemicals     Corporate     Consolidated
                                       -----------   -----------   -----------   -----------    ------------
                                                                                 
     Sales to unaffiliated customers   $ 2,174,887   $ 2,653,132   $   115,231   $        --    $ 4,943,250
     Net income (loss)                     217,021       842,243       139,131    (1,122,617)        75,778
     Total assets                          494,272       919,995        31,764       640,501      2,086,532
     Depreciation and amortization         117,497        31,133         4,928        27,418        180,976
     Capital expenditures                   52,328       104,221            --         4,158        160,707


Information by segment for the nine months ended and as of September 30, 2001:



                                          Pipe          Tank
                                        Cleaning      Cleaning      Chemicals     Corporate     Consolidated
                                       -----------   -----------   -----------   -----------    ------------
                                                                                 
     Sales to unaffiliated customers   $ 3,257,320   $   842,247   $   212,062   $        --    $ 4,311,629
     Net income (loss)                     735,213        96,699       131,588    (1,033,177)       (69,677)
     Total assets                          945,542       566,597        63,883       506,318      2,082,340
     Depreciation and amortization         137,693        16,596         4,733        33,645        192,667
     Capital expenditures                   32,496        48,964            --         1,212         82,672


We derive the majority of our revenue from two  sources,  cleaning  vacuum sewer
"CHT" pipe systems on U.S. Navy and U.S. Coast Guard vessels and cleaning bilge,
fuel, oil and CHT tanks on ships. A significant portion of the pipe cleaning has
been performed  pursuant to a five-year  contract with the U.S. Navy (Portsmouth
CHT contract),  which expired  September 2002. The pipe system cleaning pursuant
to the Portsmouth CHT contract with the U.S. Navy was 35% of consolidated  sales
during the nine months ended  September 30, 2002 compared to 51% during the nine
months ended September 30, 2001.

On September 30, 2002, the Company was awarded a new five-year contract with the
U.S. Navy to use its chemical  cleaning  technology to clean CHT systems on U.S.
Navy and other military vessels on a worldwide basis. The negotiated contract is
for  "indefinite  delivery  indefinite  quantity" task orders for the first year
award  and  four  option  years  through  the USN  Supervisor  of  Shipbuilding,
Portsmouth,  Virginia. Of all the firms responding to the Navy solicitation, two
awards were made for the contract  after careful  evaluation in accordance  with
the  solicitation  based on a  determination  of "best  value" to the Navy.  The
contract  minimum for the two awards is $107,097 while the contract  maximum for
the two awards is a total of $5,948,312 for each of the five years;  however, we
do not know the proportions as to which it will be split. Historically,  we have
found that once we are on board the ship,  we often  have the  ability to obtain
additional work.

                                                                               8

NOTE 5 - EARNINGS PER SHARE

A reconciliation of the numerators and denominators  (weighted average number of
shares   outstanding)  of  the  basic  and  diluted  earnings  per  share  (EPS)
computation  for the three and nine months ended  September 30, 2002 and 2001 is
as follows:



                                                 Three Months Ended
                                                 September 30, 2002
                                            ---------------------------
                                              Net Loss        Shares        Per Share
                                            (Numerator)    (Denominator)      Amount
                                            -----------    -------------   -----------
                                                                  
     Basic EPS                              $   (60,286)     12,004,872    $     (0.01)
                                                                           ===========
     Effect of stock options and warrants            --              --
                                            -----------     -----------
     Diluted EPS                            $   (60,286)     12,004,872    $     (0.01)
                                            ===========     ===========    ===========

                                                 Three Months Ended
                                                 September 30, 2001
                                            ---------------------------
                                            Net Income        Shares        Per Share
                                            (Numerator)    (Denominator)      Amount
                                            -----------    -------------   -----------
     Basic EPS                              $   208,060      11,798,206    $      0.02
                                                                           ===========
     Effect of stock options and warrants            --              --
                                            -----------     -----------
     Diluted EPS                            $   208,060      11,798,206    $      0.02
                                            ===========     ===========    ===========

                                                 Nine Months Ended
                                                 September 30, 2002
                                            ---------------------------
                                            Net Income        Shares        Per Share
                                            (Numerator)    (Denominator)      Amount
                                            -----------    -------------   -----------
     Basic EPS                              $    75,778      11,951,905    $      0.01
                                                                           ===========
     Effect of stock options and warrants            --          73,565
                                            -----------     -----------
     Diluted EPS                            $    75,778      12,025,470    $      0.01
                                            ===========     ===========    ===========


                                                                               9



                                                 Nine Months Ended
                                                 September 30, 2001
                                            ---------------------------
                                             Net Loss         Shares        Per Share
                                            (Numerator)    (Denominator)      Amount
                                            -----------    -------------   -----------
                                                                  
     Basic EPS                              $   (69,677)     11,768,713    $     (0.01)
                                                                           ===========

     Effect of stock options and warrants            --              --
                                            -----------     -----------
     Diluted EPS                            $   (69,677)     11,768,713    $     (0.01)
                                            ===========     ===========    ===========


NOTE 6 - RECENTLY ISSUED ACCOUNTING STANDARDS

SFAS No. 143, Accounting for Asset Retirement Obligations,  requires recognition
of the fair value of  obligations  associated  with the retirement of long-lived
assets  when there is a legal  obligation  to incur such  costs.  This amount is
accounted for as an additional element of the corresponding asset's cost, and is
depreciated  over that asset's useful life.  SFAS No. 143 will become  effective
for the Company on January 1, 2003.  The Company does not believe that this will
have a material impact on its liquidity or results of operations.

NOTE 7 - NOTES PAYABLE

During the month of January  2002,  the Company  financed  $321,914 of insurance
premiums  payable in nine monthly  installments at an annual  percentage rate of
3.68%.  During the month of May 2002, the Company  financed $47,200 of insurance
premiums  payable in nine monthly  installments at an annual  percentage rate of
3.68%

NOTE 8 - COMMITMENTS AND CONTINGENCIES

LITIGATION

A claim has been resolved in the amount of $85,000, which was charged to general
and  administrative  expenses  during the three months ended September 30, 2002.
The  resolution  reflected an economic  decision  based upon a financial  impact
evaluation necessary to resolve the matter.

NOTE 9 - INCOME TAXES

The Company's net operating loss  carryforwards  fully offset all taxable income
for the nine months ended  September 30, 2002 and therefore  there is no current
federal income tax expense. Deferred tax assets as of September 30, 2002 arising
primarily  from loss carry  forward  benefits  have been  offset by a  valuation
allowance  because of the  historical  operating  losses and the  uncertainty of
realizing such benefits.

NOTE 10 - RELEASE AND ASSIGNMENT AGREEMENT

On June 14, 2002, the Company executed a release and assignment  agreement which
assigned  all of  the  Company's  right,  title  and  interest  in any  patents,
royalties, manufacturing rights or any other rights in the product Chlor*Rid(R).
In return,  the Company  received a cash payment of $225,000  from  Chlor*Rid(R)
International. This $225,000 is accounted for as other income.

                                                                              10

Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS

                 STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

     PORTIONS OF THIS REPORT DESCRIBE HISTORICAL  INFORMATION,  SUCH AS THE 2001
AND 2002 OPERATING RESULTS,  AND WE BELIEVE THE DESCRIPTIONS TO BE ACCURATE.  IN
CONTRAST TO DESCRIBING THE PAST, SOME STATEMENTS IN THIS REPORT INDICATE THAT WE
BELIEVE  THAT  EVENTS OR  FINANCIAL  RESULTS  ARE LIKELY TO OCCUR IN THE FUTURE.
THESE  STATEMENTS  TYPICALLY  USE WORDS OR PHRASES  LIKE  "BELIEVE,"  "EXPECTS,"
"ANTICIPATES," "ESTIMATES," "WILL CONTINUE" AND SIMILAR EXPRESSIONS.  STATEMENTS
USING   THOSE   WORDS  OR  SIMILAR   EXPRESSIONS   ARE   INTENDED   TO  IDENTIFY
"FORWARD-LOOKING  STATEMENTS"  AS  THAT  TERM  IS  USED  IN  SECTION  27A OF THE
SECURITIES ACT OF 1933, AS AMENDED,  AND SECTION 21E OF THE SECURITIES  EXCHANGE
ACT OF 1934,  AS AMENDED.  FORWARD-LOOKING  STATEMENTS  INCLUDE  PROJECTIONS  OF
OPERATING  RESULTS FOR 2002 AND BEYOND,  EITHER CONCERNING A SPECIFIC SEGMENT OF
OUR BUSINESS, OR CONCERNING OUR COMPANY AS A WHOLE.

     ACTUAL  RESULTS,  HOWEVER,  MAY BE  MATERIALLY  DIFFERENT  FROM THE RESULTS
PROJECTED  IN THE  FORWARD-LOOKING  STATEMENTS,  DUE TO A  VARIETY  OF RISKS AND
UNCERTAINTIES.  THESE  RISKS  AND  UNCERTAINTIES  INCLUDE  THOSE  SET  FORTH  IN
"MANAGEMENT'S  DISCUSSION  AND  ANALYSIS OF FINANCIAL  CONDITION  AND RESULTS OF
OPERATIONS."

     THE  FORWARD-LOOKING  STATEMENTS  IN THIS REPORT ARE CURRENT ONLY AS OF THE
DATE THIS REPORT IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. AFTER THE
FILING OF THIS REPORT,  OUR EXPECTATIONS AND BELIEFS MAY CHANGE, AND WE MAY COME
TO BELIEVE THAT CERTAIN FORWARD-LOOKING  STATEMENTS IN THIS REPORT ARE NO LONGER
ACCURATE.  WE DO NOT HAVE AN OBLIGATION TO CORRECT OR REVISE ANY FORWARD-LOOKING
STATEMENTS IN THIS REPORT, EVEN IF WE BELIEVE THE FORWARD LOOKING STATEMENTS ARE
NO LONGER TRUE.

OVERVIEW

     We derive the  majority of our revenue from two  sources,  cleaning  vacuum
sewer  "CHT"  systems on U.S.  Navy and U.S.  Coast Guard  vessels and  cleaning
bilge,  fuel,  oil and CHT tanks on ships.  A  significant  portion  of the pipe
cleaning has been performed  pursuant to a five-year contract with the U.S. Navy
(Portsmouth CHT contract),  which expired September 2002. This has subjected our
Company to certain  business  risks that have caused  volatility  in our revenue
stream and our gross  margins.  We have also been subject to the  deployment and
servicing schedules of the U.S. Navy as well as the available  maintenance funds
in the Navy budget.  These factors can cause revenue to change dramatically from
one quarter to the next.  Additionally,  we have been required by our Portsmouth
CHT contract to perform work on different  classes of ships.  Performing work on
different  classes of ships can cause our gross  margins to vary widely from one
quarter to the next because we realize  higher gross margins on certain  classes
of ships than on others.  Moreover,  we are often asked to perform work on ships
outside of the state of Virginia.  When we perform work under the Portsmouth CHT
contract outside of the state of Virginia,  we incur certain reimbursable travel
costs  that  are  included  in both  revenue  and  cost  of  goods  sold.  These
reimbursable  travel costs cause gross margins to be lower than the margins that
would have otherwise been recognized had the work been performed in Virginia.

     On September  30, 2002,  the Company was awarded a new  five-year  contract
with the U.S. Navy to use its chemical cleaning  technology to clean CHT systems
on U.S. Navy and other  military  vessels on a worldwide  basis.  The negotiated
contract is for "indefinite  delivery  indefinite  quantity" task orders for the
first  year  award  and  four  option  years  through  the  USN   Supervisor  of
Shipbuilding,  Portsmouth,  Virginia.  Of all the firms  responding  to the Navy
solicitation,  two awards were made for the contract after careful evaluation in
accordance with the solicitation based on a determination of "best value" to the
Navy.  The  contract  minimum for the two awards is $107,097  while the contract
maximum for the two awards is a total of $5,948,312  for each of the five years;
however,  we do  not  know  the  proportions  as to  which  it  will  be  split.
Historically,  we have found  that once we are on board the ship,  we often have
the ability to obtain additional work.

                                                                              12

CRITICAL ACCOUNTING JUDGMENTS AND ESTIMATES

     We  consider  the  following  accounting  policies  to  be  critical  to an
understanding of our financial  statements  because their application places the
most  significant  demands on our judgment,  with  financial  reporting  results
relying on estimates about the effect of matters that are inherently  uncertain.
Specific  risks for these  critical  accounting  policies  are  described in the
following  paragraphs.  For all of these policies, we caution that future events
rarely develop  exactly as forecast,  and the best estimates  routinely  require
adjustment.

REVENUE RECOGNITION

     For chemical  product sales, we recognize  revenue at the time products are
shipped to customers.  For most service projects,  we recognize revenue when the
services are  completed.  For fixed price  contracts that are in excess of three
months, we recognize revenue on the percentage of completion method, measured as
the  percentage of cost  incurred to date of the  estimated  total cost for each
contract.  We use this method  because we consider the  percentage  of the total
cost to be the best available measure of progress on these contracts.

     Contract costs include all direct  material,  subcontract  labor, and other
costs related to contract performance,  such as indirect labor, supplies, tools,
and repairs.  Selling,  general, and administrative costs are charged to expense
as incurred.  Provisions for estimated losses on uncompleted  contracts are made
in the period in which such losses are determined.  Changes in job  performance,
job  conditions,  and  estimated  profitability,  including  those  arising from
contract  penalty  provisions  and  final  contract  settlements  may  result in
revisions to estimates of contract  costs and profits and are  recognized in the
period in which the revisions are determined.

     The current asset,  "costs and estimated  earnings in excess of billings on
uncompleted  contracts"  represents  revenue  recognized  in excess  of  amounts
billed.  The  current  liability,  "billings  in excess of costs on  uncompleted
contracts," represents billings in excess of revenue recognized.

ALLOWANCE FOR DOUBTFUL ACCOUNTS

     We analyze accounts receivable to determine the ultimate  collectibility of
those accounts.  If information is available to us to make a determination  that
there exists a reasonable  probability  that an account will not be collectible,
we  create a  reserve  for that  account  at the time of the  determination  and
recognize a related expense. If the account is later collected,  the reserve and
expense are  reversed in the current  accounting  period.  Since we must use our
best judgment as to which accounts will be collected, there exists the risk that
some accounts  might not be collected  and thus could have a negative  impact on
our liquidity and results of operations.

DEFERRED TAX ASSETS

     Deferred  taxes are  provided on a liability  method  whereby  deferred tax
assets are  recognized  for deductible  temporary  differences  and deferred tax
liabilities  are  recognized  for  taxable  temporary   differences.   Temporary
differences  are the  differences  between  the  reported  amounts of assets and
liabilities and their tax bases.  Deferred tax assets are reduced by a valuation
allowance  when it is determined to be more likely than not that some portion or
all of the  deferred  tax assets will not be  realized.  Deferred tax assets and
liabilities are adjusted for the effects of changes in tax laws and rates on the
date of enactment.

                                                                              13

IMPAIRMENT OF LONG-LIVED ASSETS

     We  periodically  evaluate  the  carrying  value of  long-lived  assets and
intangibles.  We review  long-lived assets and certain  identifiable  intangible
assets  to be held and used in  operations  for  potential  impairment  whenever
events or circumstances indicate that the carrying amount of an asset may not be
fully  recoverable.  An impairment loss is recognized if the sum of the expected
long-term  undiscounted  cash  flows is less  than the  carrying  amount  of the
long-lived  assets being evaluated.  Future losses may be recorded if cash flows
are less than expected.

ACCRUALS

     Loss  contingencies  are recorded as liabilities when it is probable that a
liability has been incurred and the amount of the loss is reasonably  estimable.
Disclosure is required when there is a reasonable  possibility that the ultimate
loss will  exceed  the  recorded  provision.  Contingent  liabilities  are often
resolved over long time periods. Estimating probable losses requires analysis of
multiple  forecasts that often depend on judgments  about  potential  actions by
third parties such as regulators.

     Other  significant  accounting  policies,  not  involving the same level of
measurement  uncertainties as those discussed above, are nevertheless  important
to a complete understanding of the financial statements.

RESULTS OF OPERATIONS

THREE MONTHS ENDED SEPTEMBER 30, 2002 COMPARED WITH THREE MONTHS ENDED
SEPTEMBER 30, 2001

     Sales  for the three  months  ended  September  30,  2002  were  $1,770,863
compared with $1,740,621  during the same period in 2001. Pipe cleaning services
accounted  for $352,779  during the three months ended  September  30, 2002,  of
which  $257,153 was billed  under the  Portsmouth  CHT contract  with the United
States  Navy.  For the three  months ended  September  30,  2001,  pipe-cleaning
services  accounted  for  $1,055,988  of which  $745,594  was  billed  under the
Portsmouth CHT contract.  Tank cleaning  services totaled  $1,384,485 during the
three months ended  September 30, 2002  compared  with $582,670  during the same
period in 2001.  Industrial  chemical sales were $33,599 during the three months
ended September 30, 2002 compared with $101,963 during the same period in 2001.

     The pipe system  cleaning  pursuant to the Portsmouth CHT contract with the
U.S. Navy was 15% of consolidated  sales during the three months ended September
30, 2002 compared to 43% during the three months ended September 30, 2001.

     Sales of pipe cleaning services decreased 67% during the three months ended
September  30, 2002  compared to the same period in 2001.  The  decrease in pipe
cleaning  revenue  represents a slowdown in orders for cleaning  pipe systems on
board U.S. Navy and U.S.  Coast Guard vessels.  Sales of tank cleaning  services
increased 138% during the three months ended  September 30, 2002 compared to the
same  period  in 2001.  The  increase  in tank  cleaning  revenue  reflects  our
successful  penetration into the tank cleaning market, strong general demand for
tank cleaning  services and additional demand for our services in particular due

                                                                              14

to our focus on customer  satisfaction.  Sales of industrial chemicals decreased
67% during the three months ended September 30, 2002 compared to the same period
in 2001. The reduction in chemical sales represents the lack of any Chlor*Rid(R)
chemical  sales  during the period as a result of the  assignment  of all of the
Company's  right,  title and interest in any patents,  royalties,  manufacturing
rights or any other rights in the product Chlor*Rid(R) during the second quarter
of 2002.

     Consolidated gross margins remained relatively flat at 48% during the three
months  ended  September  30, 2002  compared  with 49% during the same period in
2001.

     Performing  pipe-cleaning  services on different classes of ships can cause
our gross  margins to vary widely  from one quarter to the next  because we make
higher  gross  margins  on  certain  classes  of  ships  than  we do on  others.
Additionally,  when we perform work under the Portsmouth CHT contract outside of
the state of  Virginia,  we incur  certain  reimbursable  travel  costs that are
included in both revenue and cost of goods sold. These reimbursable travel costs
cause gross margins to be lower than the margins that would have  otherwise been
recognized had the work been performed in Virginia.

     We  anticipate  that  future  gross  margins  from pipe  cleaning  and tank
cleaning  will  fluctuate  with  changes  in revenue  mix and other  operational
factors  such as our  ability  to bid work at  profitable  levels as well as our
ability to control costs on projects.

     Gross profit  decreased  slightly to $843,792 during the three months ended
September  30,  2002 from  $846,331  during the same  period in 2001.  The small
change in gross  profit  reflects the  relatively  flat revenue and gross margin
from one period to the next.

     Selling  expenses  increased  to  $123,471  during the three  months  ended
September 30, 2002 from $60,455 during the same period in 2001 while general and
administrative  expenses  increased  to  $762,759  for the  three  months  ended
September 30, 2002 from $560,920 during the same period in 2001. The increase in
selling  expenses was  primarily the result of  additional  sales  personnel and
related marketing expenses. General and administrative expenses were higher as a
result of increases in legal expenses and bad debt expenses.

     For the three months ended  September  30, 2002,  we incurred a net loss of
$60,286 compared to net income of $208,060 during the same period in 2001.

NINE MONTHS ENDED SEPTEMBER 30, 2002 COMPARED WITH NINE MONTHS ENDED
SEPTEMBER 30, 2001,

     Sales for the nine months ended September 30, 2002 were $4,943,250 compared
with $4,311,629 during the same period in 2001. Pipe cleaning services accounted
for  $2,174,887  during the nine  months  ended  September  30,  2002,  of which
$1,744,211  was billed under the  Portsmouth CHT contract with the United States
Navy.  For the nine months  ended  September  30, 2001,  pipe-cleaning  services
accounted for $3,257,320 of which $2,201,886 was billed under the Portsmouth CHT
contract. Tank cleaning services totaled $2,653,132 during the nine months ended
September  30,  2002  compared  with  $842,247  during the same  period in 2001.
Industrial  chemical sales were $115,231  during the nine months ended September
30, 2002 compared with $212,061 during the same period in 2001.

                                                                              15

     The pipe system  cleaning  pursuant to the Portsmouth CHT contract with the
U.S. Navy was 35% of  consolidated  sales during the nine months ended September
30, 2002 compared to 51% during the nine months ended September 30, 2001.

     Sales of pipe cleaning services  decreased 33% during the nine months ended
September  30, 2002  compared to the same period in 2001.  The  decrease in pipe
cleaning  revenue  represents a slowdown in orders for cleaning  pipe systems on
board U.S. Navy and U.S.  Coast Guard vessels.  Sales of tank cleaning  services
increased  315% during the nine months ended  September 30, 2002 compared to the
same  period  in 2001.  The  increase  in tank  cleaning  revenue  reflects  our
successful  penetration into the tank cleaning market, strong general demand for
tank cleaning  services and additional demand for our services in particular due
to our focus on customer  satisfaction.  Sales of industrial chemicals decreased
46% during the nine months ended  September 30, 2002 compared to the same period
in 2001. The reduction in chemical sales represents the lack of any Chlor*Rid(R)
chemical  sales  during the period as a result of the  assignment  of all of the
Company's  right,  title and interest in any patents,  royalties,  manufacturing
rights or any other rights in the product Chlor*Rid(R) during the second quarter
of 2002.

     Consolidated  gross margin was 45% during the nine months  ended  September
30,  2002  compared  with 43% during the same  period in 2001.  The  increase in
consolidated  gross  margin  was the  result of  higher  gross  margins  in tank
cleaning as compared to the same period in 2001.

     Performing pipe cleaning  services on different  classes of ships can cause
our gross  margins to vary widely  from one quarter to the next  because we make
higher  gross  margins  on  certain  classes  of  ships  than  we do on  others.
Additionally,  when we perform work under the Portsmouth CHT contract outside of
the state of  Virginia,  we incur  certain  reimbursable  travel  costs that are
included in both revenue and cost of goods sold. These reimbursable travel costs
cause gross margins to be lower than the margins that would have  otherwise been
recognized had the work been performed in Virginia.

     We  anticipate  that  future  gross  margins  from pipe  cleaning  and tank
cleaning  will  fluctuate  with  changes  in revenue  mix and other  operational
factors  such as our  ability  to bid work at  profitable  levels as well as our
ability to control costs on projects.

     Gross profit increased to $2,229,830 during the nine months ended September
30, 2002 from  $1,857,518  during the same period in 2001. The increase in gross
profit  was the  result of higher  consolidated  revenue  combined  with  higher
consolidated gross margins.

     Selling  expenses  increased  to  $378,811  during  the nine  months  ended
September  30, 2002 from  $199,790  during the same period in 2001 while general
and administrative expenses increased to $1,943,022 during the nine months ended
September 30, 2002 from $1,739,467  during the same period in 2001. The increase
in selling  expenses was primarily the result of additional  sales personnel and
related marketing expenses. General and administrative expenses were higher as a
result of increases in legal expenses and bad debt expenses.

                                                                              16

     On June 14, 2002, the Company  executed a release and assignment  agreement
which  assigned all of the Company's  right,  title and interest in any patents,
royalties, manufacturing rights or any other rights in the product Chlor*Rid(R).
In return,  the Company  received a cash payment of $225,000  from  Chlor*Rid(R)
International.  This $225,000 is accounted for as other income.  During the nine
months ended  September 30, 2001,  the Company sold an asset and realized a gain
of $52,378, which is included in other income.

     For the nine months ended  September  30, 2002,  we generated net income of
$75,778 compared to a net loss of $69,677 for the same period in 2001.

LIQUIDITY AND CAPITAL RESOURCES

     Cash was  $121,158 at  September  30, 2002 and $75,759 at December 31, 2001
while working capital was $492,014 and $397,407 on those  respective  dates. The
increase in cash and working capital is primarily the result of our net income.

     The  Company  has a  factoring  arrangement  whereby  the factor  purchases
eligible  receivables  and advances 85% of the purchased  amount to our Company.
Purchased  receivables may not exceed  $1,000,000 at any one time.  Either party
may cancel the arrangement with 30 days notice. At September 30, 2002, there was
$616,401 of factored  receivables  of which we have  received  $523,941 from the
factor.  This  $523,941  and  $4,623  in  interest  expense  are  not  shown  as
receivables. This arrangement is accounted for as a sale of receivables on which
the factor has recourse to the 15% residual of aggregate  receivables  purchased
and  outstanding.  Interest payable by us to the factor is calculated as a fixed
discount  fee equal to 0.75% of the  amount of the  receivable  factored  plus a
variable (1.5% above the institutions  base rate, with a minimum of 7%) discount
fee  computed on the amount  advanced to us and  accruing on the basis of actual
days elapsed from the date of the 85% advance  until 5 days after  collection of
such account  receivable  by the factor at a per annum rate equal to an internal
rate set by the factor.  The rate at  September  30, 2002 was 7%. In  connection
with this agreement, we are required to maintain certain financial covenants. In
the event of a breach of representation,  warranty or agreement, the institution
has a security interest in our assets.

     Our existing  five-year  Portsmouth CHT contract with the U.S. Navy expired
in September  2002.  This contract had been  responsible for the majority of our
consolidated revenue for several years.

     On October 14, 2002, the Company was awarded a new five-year  contract with
the U.S.  Navy to use its chemical  cleaning  technology to clean CHT systems on
U.S.  Navy and other  military  vessels on a  worldwide  basis.  The  negotiated
contract is for "indefinite  delivery  indefinite  quantity" task orders for the
first  year  award  and  four  option  years  through  the  USN   Supervisor  of
Shipbuilding,  Portsmouth,  Virginia.  Of all the firms  responding  to the Navy
solicitation,  two awards were made for the contract after careful evaluation in
accordance with the solicitation based on a determination of "best value" to the
Navy.  The  contract  minimum for the two awards is $107,097  while the contract
maximum for the two awards is a total of $5,948,312  for each of the five years;
however,  we do  not  know  the  proportions  as to  which  it  will  be  split.
Historically,  we have found  that once we are on board the ship,  we often have
the ability to obtain additional work.

     We rely primarily on our internally  generated  operating cash flow and our
factoring  arrangement  to fund our  operations  and our business.  We currently
contract with a few major customers  responsible  for a large  percentage of our
revenue and we expect the high  concentration  levels to continue  through 2002.
Thus,  any  material  delay,  cancellation  or  reduction  of orders  from these
customers could have a material adverse effect on our liquidity and operations.

     The table below describes our  contractual  obligations as of September 30,
2002 to make future payments under contracts such as debt and lease agreements:

             Contractual
             Obligations                          Payments Due by Fiscal Year
             -----------                          ---------------------------
                                                    2002      2003      2004
                                                  -------   -------   -------
Long-Term Debt and Other Financing Arrangements   $53,307   $11,940   $    --
Capital Lease Obligations                           3,428     1,232        --
Operating Leases                                   13,118    50,757     3,700

                                                                              17

     While we believe that we will not need to raise additional  capital because
our  current  cash  and  expected  cash  flows  generated  from  operations  are
anticipated to be sufficient for the foreseeable  future, we may, in the future,
sell additional securities to raise capital. Any such sale, if necessary,  could
substantially  dilute  the  interest  of our  existing  stockholders.  We cannot
provide any  assurance  that we will be able to sell  additional  securities  at
terms  acceptable to us. We may, in the future,  make  acquisitions by utilizing
debt financing if available.  Any such acquisition and debt financing could have
a material adverse impact on our liquidity and results of operations.

Item 3. CONTROLS AND PROCEDURES

     Based  on  their  evaluation  of  the  effectiveness  of our  controls  and
procedures conducted as of a date within 90 days prior to the date of the filing
of this report,  our Chief Executive  Officer and Chief  Financial  Officer have
each  concluded  that our  disclosure  controls and procedures are effective and
sufficient  to (a)  assure  that  we  record,  process,  summarize,  and  report
information  required to be disclosed by us in our periodic  reports filed under
the Securities  Exchange Act within the time periods specified by the Securities
and Exchange  Commission's  rules and forms;  and (b) accumulate and communicate
information  required  to  be  disclosed  by  us  in  our  periodic  reports  to
management,  as appropriate to allow for timely  decision  making  regarding the
required disclosure.

     Subsequent  to the  date of  their  evaluation,  there  have  not  been any
significant  changes in our  internal  controls or in other  factors  that could
significantly affect these controls, including any corrective action with regard
to significant deficiencies and material weaknesses.

                                                                              18

                           PART II: OTHER INFORMATION

ITEM 2. CHANGES IN SECURITIES

RECENT SALES OF UNREGISTERED SECURITIES

During the third  quarter of 2002 the  Company  issued  60,000  shares of common
stock as  compensation  to its outside  Board of  Directors.  These  shares were
issued  under an  exemption  from  registration  pursuant to Section 4(2) of the
Securities Act of 1933.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

Reports on Form 8-K:  None

Exhibits:

10.18     Employment Agreement between S. Steven Carl and the Registrant.

10.19     Solicitation,  Offer and  Award  Contract  dated  September  30,  2002
          between the Supervisor of Shipbuilding, C & R, USN and the
          Registrant. *

  99.1    Certification  of the  Chief  Executive  Officer  of  the  Registrant,
          pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906
          of the Sarbanes-Oxley Act of 2002.

  99.2    Certification  of the  Chief  Financial  Officer  of  the  Registrant,
          pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
          of the Sarbanes-Oxley Act of 2002.

* Certain information in this exhibit has been omitted and filed separately with
the  Securities  and  Exchange  Commission.   Confidential  treatment  has  been
requested with respect to the omitted portions.

                                   SIGNATURES

In accordance with the  requirements of the Exchange Act, the registrant  caused
this  report to be  signed on its  behalf  by the  undersigned,  thereunto  duly
authorized.

                                        H.E.R.C. PRODUCTS INCORPORATED
                                        (Registrant)


Date: November 13, 2002                 By: /s/ S. Steven Carl
                                            ------------------------------------
                                            S. Steven Carl
                                            Chief Executive Officer

                                        By: /s/ Michael H. Harader
                                            ------------------------------------
                                            Michael H. Harader
                                            Chief Financial Officer
                                            (Principal Financial and
                                            Accounting Officer)

                                                                              19

                                  CERTIFICATION

     I, S. Steven Carl, certify that:

     1. I have  reviewed  this  quarterly  report  on Form  10-QSB  of  H.E.R.C.
Products Incorporated;

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information  included in this quarterly  report,  fairly present in all material
respects the financial condition,  results of operations,  and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

     4. The  registrant's  other  certifying  officers and I are responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

          a) Designed  such  disclosure  controls and  procedures to ensure that
     material information relating to the registrant, including its consolidated
     subsidiaries,  is  made  known  to  us by  others  within  those  entities,
     particularly  during  the period in which  this  quarterly  report is being
     prepared;

          b) Evaluated the effectiveness of the registrant's disclosure controls
     and procedures as of a date within 90 days prior to the filing date of this
     quarterly report (the "Evaluation Date"); and

          c)  Presented  in this  quarterly  report  our  conclusions  about the
     effectiveness  of the  disclosure  controls  and  procedures  based  on our
     evaluation as of the Evaluation Date;

     5. The registrant's other certifying  officers and I have disclosed,  based
on our most  recent  evaluation,  to the  registrant's  auditors  and the  audit
committee of the  registrant's  board of directors  (or persons  performing  the
equivalent function):

          a) All significant deficiencies in the design or operation of internal
     controls which could adversely affect the  registrant's  ability to record,
     process,  summarize,  and report financial data and have identified for the
     registrant's auditors any material weaknesses in internal controls; and

          b) Any fraud,  whether or not material,  that  involves  management or
     other employees who have a significant  role in the  registrant's  internal
     controls; and

     6. The registrant's other certifying  officers and I have indicated in this
quarterly report whether there were significant  changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the date of our most recent  evaluation,  including any corrective  actions with
regard to significant deficiencies and material weaknesses.

Date: November 13, 2002

                                        /s/ S. Steven Carl
                                        ----------------------------------------
                                        S. Steven Carl
                                        Chief Executive Officer and President

                                                                              20

                                  CERTIFICATION

     I, Michael H. Harader, certify that:

     1. I have  reviewed  this  quarterly  report  on Form  10-QSB  of  H.E.R.C.
Products Incorporated;

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information  included in this quarterly  report,  fairly present in all material
respects the financial condition,  results of operations,  and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

     4. The  registrant's  other  certifying  officers and I are responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

          a) Designed  such  disclosure  controls and  procedures to ensure that
     material information relating to the registrant, including its consolidated
     subsidiaries,  is  made  known  to  us by  others  within  those  entities,
     particularly  during  the period in which  this  quarterly  report is being
     prepared;

          b) Evaluated the effectiveness of the registrant's disclosure controls
     and procedures as of a date within 90 days prior to the filing date of this
     quarterly report (the "Evaluation Date"); and

          c)  Presented  in this  quarterly  report  our  conclusions  about the
     effectiveness  of the  disclosure  controls  and  procedures  based  on our
     evaluation as of the Evaluation Date;

     5. The registrant's other certifying  officers and I have disclosed,  based
on our most  recent  evaluation,  to the  registrant's  auditors  and the  audit
committee of the  registrant's  board of directors  (or persons  performing  the
equivalent function):

          a) All significant deficiencies in the design or operation of internal
     controls which could adversely affect the  registrant's  ability to record,
     process,  summarize,  and report financial data and have identified for the
     registrant's auditors any material weaknesses in internal controls; and

          b) Any fraud,  whether or not material,  that  involves  management or
     other employees who have a significant  role in the  registrant's  internal
     controls; and

     6. The registrant's other certifying  officers and I have indicated in this
quarterly report whether there were significant  changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the date of our most recent  evaluation,  including any corrective  actions with
regard to significant deficiencies and material weaknesses.

Date: November 13, 2002

                                        /s/ Michael H. Harader
                                        ----------------------------------------
                                        Michael H. Harader
                                        Chief Financial Officer and
                                        Vice President -- Finance

                                                                              21